Brief problem-solving therapy for antenatal depressive symptoms in primary care in rural Ethiopia: protocol for a randomised, controlled feasibility trial.

Antenatal depression Low- and middle-income countries Perinatal mental health; Ethiopia Problem solving therapy Psychological interventions

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
30 Jan 2021
Historique:
received: 11 08 2020
accepted: 08 01 2021
entrez: 30 1 2021
pubmed: 31 1 2021
medline: 31 1 2021
Statut: epublish

Résumé

Despite a high prevalence of antenatal depression in low- and middle-income countries, there is very little evidence for contextually adapted psychological interventions delivered in rural African settings. The aims of this study are (1) to examine the feasibility of procedures for a future fully powered efficacy trial of contextually adapted brief problem solving therapy (PST) for antenatal depression in rural Ethiopia, and (2) to investigate the acceptability, fidelity and feasibility of delivery of PST in routine antenatal care. Design: A randomised, controlled, feasibility trial and mixed method process evaluation. Consecutive women attending antenatal clinics in two primary care facilities in rural Ethiopian districts. Eligibility criteria: (1) disabling levels of depressive symptoms (Patient Health Questionnaire (PHQ-9) score of five or more and positive for the 10 Four sessions of adapted PST delivered by trained and supervised antenatal care staff over a maximum period of eight weeks. enhanced usual care (EUC). n = 50. Randomisation: individual randomisation stratified by intimate partner violence (IPV). Allocation: central phone allocation. Outcome assessors and statistician masked to allocation status. Primary feasibility trial outcome: dropout rate. Primary future efficacy trial outcome: change in PHQ-9 score, assessed 9 weeks after recruitment. anxiety symptoms, trauma symptoms, intimate partner violence, disability, healthcare costs at 9 weeks; postnatal outcomes (perinatal and neonatal complications, onset of breast feeding, child health) assessed 4-6 weeks postnatal. Other trial feasibility indicators: recruitment, number and duration of sessions attended. Audio-recording of randomly selected sessions and in-depth interviews with purposively selected participants, healthcare providers and supervisors will be analysed thematically to explore the acceptability and feasibility of the trial procedures and fidelity of the delivery of PST. The findings of the study will be used to inform the design of a fully powered efficacy trial of brief PST for antenatal depression in routine care in rural Ethiopia. The protocol was registered in the Pan-African clinical trials registry, (PACTR): registration number: PACTR202008712234907 on 18/08/2020; URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9578 .

Sections du résumé

BACKGROUND BACKGROUND
Despite a high prevalence of antenatal depression in low- and middle-income countries, there is very little evidence for contextually adapted psychological interventions delivered in rural African settings. The aims of this study are (1) to examine the feasibility of procedures for a future fully powered efficacy trial of contextually adapted brief problem solving therapy (PST) for antenatal depression in rural Ethiopia, and (2) to investigate the acceptability, fidelity and feasibility of delivery of PST in routine antenatal care.
METHODS METHODS
Design: A randomised, controlled, feasibility trial and mixed method process evaluation.
PARTICIPANTS METHODS
Consecutive women attending antenatal clinics in two primary care facilities in rural Ethiopian districts. Eligibility criteria: (1) disabling levels of depressive symptoms (Patient Health Questionnaire (PHQ-9) score of five or more and positive for the 10
INTERVENTION METHODS
Four sessions of adapted PST delivered by trained and supervised antenatal care staff over a maximum period of eight weeks.
CONTROL METHODS
enhanced usual care (EUC).
SAMPLE SIZE METHODS
n = 50. Randomisation: individual randomisation stratified by intimate partner violence (IPV). Allocation: central phone allocation. Outcome assessors and statistician masked to allocation status. Primary feasibility trial outcome: dropout rate. Primary future efficacy trial outcome: change in PHQ-9 score, assessed 9 weeks after recruitment.
SECONDARY OUTCOMES RESULTS
anxiety symptoms, trauma symptoms, intimate partner violence, disability, healthcare costs at 9 weeks; postnatal outcomes (perinatal and neonatal complications, onset of breast feeding, child health) assessed 4-6 weeks postnatal. Other trial feasibility indicators: recruitment, number and duration of sessions attended. Audio-recording of randomly selected sessions and in-depth interviews with purposively selected participants, healthcare providers and supervisors will be analysed thematically to explore the acceptability and feasibility of the trial procedures and fidelity of the delivery of PST.
DISCUSSION CONCLUSIONS
The findings of the study will be used to inform the design of a fully powered efficacy trial of brief PST for antenatal depression in routine care in rural Ethiopia.
TRIAL REGISTRATION BACKGROUND
The protocol was registered in the Pan-African clinical trials registry, (PACTR): registration number: PACTR202008712234907 on 18/08/2020; URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9578 .

Identifiants

pubmed: 33514447
doi: 10.1186/s40814-021-00773-8
pii: 10.1186/s40814-021-00773-8
pmc: PMC7846490
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Subventions

Organisme : Medical Research Council
ID : MR/M014290/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R018464/1
Pays : United Kingdom
Organisme : Welcome Trust through Deltas Africa Initiative
ID : DEL-15-01

Références

Bull World Health Organ. 2012 Feb 1;90(2):139G-149G
pubmed: 22423165
Lancet. 2014 Nov 15;384(9956):1800-19
pubmed: 25455250
BMC Psychiatry. 2015 Jun 30;15:136
pubmed: 26122982
Nutr J. 2016 Jul 11;15(1):64
pubmed: 27401187
Mayo Clin Proc. 2007 Nov;82(11):1395-402
pubmed: 17976360
Clin Ther. 2006 Nov;28(11):1882-91
pubmed: 17213009
Behav Res Ther. 2011 Sep;49(9):523-8
pubmed: 21788012
J Affect Disord. 2016 Oct;203:121-129
pubmed: 27285725
Arch Suicide Res. 2012;16(4):287-302
pubmed: 23137219
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
BMC Psychol. 2018 Jul 17;6(1):31
pubmed: 30016997
Bull World Health Organ. 2013 Aug 1;91(8):593-601I
pubmed: 23940407
Clin Psychol Rev. 2009 Jun;29(4):348-53
pubmed: 19299058
BMC Health Serv Res. 2018 Mar 23;18(1):205
pubmed: 29566680
Health Technol Assess. 2018 May;22(30):1-220
pubmed: 29856312
Annu Rev Clin Psychol. 2017 May 8;13:149-181
pubmed: 28482687
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):113-33
pubmed: 24054170
J Clin Epidemiol. 2015 Nov;68(11):1375-9
pubmed: 26146089
J Womens Health (Larchmt). 2011 Jul;20(7):983-9
pubmed: 21668382
BMC Public Health. 2011 Oct 26;11:828
pubmed: 22029430
BMC Psychiatry. 2011 Sep 30;11:156
pubmed: 21961801
BMC Pregnancy Childbirth. 2016 Oct 10;16(1):301
pubmed: 27724876
Eur J Intern Med. 2009 Jul;20(4):411-4
pubmed: 19524185
PLoS Med. 2012;9(12):e1001359
pubmed: 23300387
Psychol Assess. 2012 Jun;24(2):313-27
pubmed: 21928912
J Consult Clin Psychol. 2008 Dec;76(6):933-43
pubmed: 19045962
J Affect Disord. 2010 Apr;122(1-2):102-8
pubmed: 19615753
Clin Pediatr (Phila). 2007 Mar;46(2):127-34
pubmed: 17325085
Behav Res Ther. 2015 Jun;69:11-21
pubmed: 25847276
BMJ Glob Health. 2018 Nov 16;3(Suppl 5):e001108
pubmed: 30498596
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMC Psychiatry. 2010 Apr 30;10:32
pubmed: 20433695
BMC Pregnancy Childbirth. 2020 Jun 22;20(1):371
pubmed: 32571246
Glob Ment Health (Camb). 2015;2:
pubmed: 28593049
Dialogues Clin Neurosci. 2011;13(1):7-23
pubmed: 21485743
Br J Psychiatry. 2016 Jan;208 Suppl 56:s4-12
pubmed: 26447174
Int J Ment Health Syst. 2018 Sep 20;12:50
pubmed: 30250501
Lancet. 2006 Oct 7;368(9543):1260-9
pubmed: 17027732
J Am Board Fam Med. 2018 Jan-Feb;31(1):139-150
pubmed: 29330248
Arch Gen Psychiatry. 2010 Oct;67(10):1012-24
pubmed: 20921117
Trials. 2020 Jun 1;21(1):454
pubmed: 32487250
J Affect Disord. 2012 Feb;136(3):340-9
pubmed: 22196052
Prim Care Companion CNS Disord. 2013;15(6):
pubmed: 24800125
Psychol Med. 2014 Apr;44(6):1131-46
pubmed: 23866176
BMC Health Serv Res. 2016 Feb 16;16:53
pubmed: 26880075
J Nerv Ment Dis. 2001 Aug;189(8):498-506
pubmed: 11531201
AIDS Care. 2015;27(1):41-6
pubmed: 25105215
PLoS One. 2012;7(10):e48396
pubmed: 23110236
Seishin Shinkeigaku Zasshi. 2015;117(11):902-9
pubmed: 26901890
Trials. 2016 Feb 02;17:59
pubmed: 26830029
Int J Ment Health Syst. 2018 Jul 28;12:42
pubmed: 30069229
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMC Psychiatry. 2016 Jun 10;16:196
pubmed: 27287387
BMC Psychiatry. 2017 Aug 22;17(1):301
pubmed: 28830395
Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):9-16
pubmed: 22055108
BMC Pregnancy Childbirth. 2017 Jun 29;17(1):206
pubmed: 28662641
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Br J Psychiatry. 2019 Sep;215(3):528-535
pubmed: 30767826
Addict Behav. 2014 Jan;39(1):122-6
pubmed: 24090621
J Abnorm Psychol. 2008 Aug;117(3):552-60
pubmed: 18729608
J Affect Disord. 2015 Nov 1;186:32-9
pubmed: 26226431
Clin Psychol Rev. 2007 Jan;27(1):46-57
pubmed: 16480801
J Affect Disord. 2008 Jun;108(3):251-62
pubmed: 18055019
Am J Geriatr Psychiatry. 2015 Dec;23(12):1307-1314
pubmed: 26628206
BMC Psychiatry. 2018 Feb 8;18(1):41
pubmed: 29422037
Int J Geriatr Psychiatry. 2016 May;31(5):526-35
pubmed: 26437368
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133

Auteurs

Tesera Bitew (T)

Department of Psychology, Institute of Educational and Behavioural Sciences, Debre Markos University, Debre Markos, Ethiopia. tesera2016@gmail.com.
Department of Psychiatry, College of Health Sciences, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia. tesera2016@gmail.com.

Roxanne Keynejad (R)

Institute of Psychiatry, Psychology & Neuroscience, Section of Women's Mental Health, King's College London, London, UK.

Bronwyn Myers (B)

Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa.

Simone Honikman (S)

Department of Psychiatry and Mental Health, Perinatal Mental Health Project, University of Cape Town, Cape Town, South Africa.

Girmay Medhin (G)

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.

Fikirte Girma (F)

Department of Psychiatry, College of Health Sciences, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.

Louise Howard (L)

Institute of Psychiatry, Psychology & Neuroscience, Section of Women's Mental Health, King's College London, London, UK.

Katherine Sorsdahl (K)

Department of Psychiatry and Mental Health, Alan J. Fisher Centre for Public Mental Health, University of Cape Town, Cape Town, South Africa.

Charlotte Hanlon (C)

Department of Psychiatry, College of Health Sciences, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Health Service and Population Research Department, Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Classifications MeSH